Results 181 to 190 of about 93,945 (299)

Impact of RAS/RAF Mutations on Metastatic Treatment Response Following Total Neoadjuvant Therapy in Patients With Stage IV Rectal Cancer

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
There is limited understanding of the impact of underlying RAS/RAF mutational status on total neoadjuvant therapy metastatic tumor response rates in curative Stage IV rectal cancer patients. Complete metastatic tumor response to TNT was demonstrated in half as many mRAS as wtRAS patients and disease progression was higher in patients harboring RAS ...
Tracy R. Fitzsimmons   +8 more
wiley   +1 more source

Bridging the gap: modern pharyngolaryngoesophagectomy techniques and the rise of neoadjuvant/immunotherapy approaches. [PDF]

open access: yesWorld J Surg Oncol
Nteka F   +8 more
europepmc   +1 more source

Evolving Trends in Laryngeal Cancer Mortality in the United States, 1999–2024: A Population‐Based Analysis With Subgroup Stratified Trends through 2020

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
Laryngeal cancer mortality in the United States declined from 1999 to 2016, followed by a plateau through 2024. Disparities persist, with males and NH‐Black populations experiencing disproportionately higher mortality. Continued regional and demographic differences highlight the need to strengthen prevention, early detection, and targeted public health
Aryan Tareen   +10 more
wiley   +1 more source

Nimotuzumab Combined With Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma and Nasopharyngeal Carcinoma: A Systematic Review and Meta‐Analysis

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
This meta‐analysis of 18 studies (3962 patients) demonstrates that nimotuzumab combined with chemoradiotherapy significantly improves overall survival and progression‐free survival in locally advanced head and neck squamous cell carcinoma, without increasing severe toxicity.
Chengzheng Bao   +6 more
wiley   +1 more source

Seven Years of Watch and Wait With Rectal Cancer—Reflections and Optimisations

open access: yesANZ Journal of Surgery, EarlyView.
ABSTRACT Purpose Sir Charles Gairdner Hospital (SCGH) commenced an observation strategy in patients with a complete clinical response, Watch and Wait (W&W), for rectal adenocarcinoma in 2017 using a rigorous surveillance protocol. Our earlier results (2017–2019) have been published.
Ben Finlay   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy